Q1: 2026-05-11 Earnings Summary EPS of $0.52 beats by $0.11  |  Revenue of $132.87M (4,158.49% Y/Y) beats by $13.46M Liquidia Corporation ( LQDA ) Bank of America Global Healthcare Conference 2026 May 13, 2026 11:40 AM EDT Company Participants Michael Kaseta - COO & CFO Jason Adair - Chief Business Officer Conference Call Participants Jason Gerberry - BofA Securities, Research Division Presentation Jason Gerberry BofA Securities, Research Division My name is Jason Gerberry. I cover pharma and biotech at BofA. I'm pleased to be introducing Liquidia. And joining us is Mike Kaseta, CFO and COO; and Jason Adair, Chief Business Officer. Question-and-Answer Session Jason Gerberry BofA Securities, Research Division So gentlemen, thanks for joining us. Liquidia is -- has one of the more interesting commercial launches in biopharma since, I believe, June of last year. And so we'll talk about that, your drug YUTREPIA for pulmonary arterial hypertension and PH-ILD.…